A cancer diagnosis can be scary. Your imagination might be working overtime, playing out best and worst-case scenarios. It’s normal. There’s so much to learn about which treatment is right for you, and it can be unsettling not to know how this will all shake out.
Prolaris is a genetic test for untreated men with prostate cancer that can determine how quickly the cancer is growing.
Prolaris helps provide clarity about your cancer’s behavior, so you can make informed decisions about your treatment with confidence.
Any patient diagnosed with localized prostate cancer is a candidate for Prolaris testing. There is no need to undergo any additional biopsies since all patients with prostate cancer have already received a prostate biopsy.
Learn how genetic testing can determine the best prostate cancer treatment for you.
The Prolaris test adds clinically-proven, objective information to subjective diagnostic tools like PSA and Gleason. It gives you clear answers to some of your most pressing questions, like how aggressive is my prostate cancer?
Be proactive and request the test from your doctor.
View our guide on:
Tips for Talking to YourHealthcare ProviderAbout Prolaris
After the test is ordered, Myriad will obtain the necessary cancer tissue from an existing biopsy.
Myriad looks at your unique genetic information using the latest in sequencing.
Once results are available, they are sent securely to your doctor’s office. Your doctor will help you understand the results.
After a prostate cancer diagnosis, choosing an appropriate treatment path can be incredibly stressful for you and your loved ones. Further complicating the problem is that unlike many other forms of cancer, there are several ways that Prostate cancer can be treated.
The Prolaris test results come with a patient-friendly summary page designed to help you clearly and confidently understand which treatment pathway is right for you.
Men with Prostate cancer that is not considered to be aggressive may be safely monitored using Active Surveillance. While it is normal to feel some unease with choosing to just watch your cancer, Active Surveillance is the recommended management option for most men with lower risk cancers.
One form of treatment
Men with more aggressive tumors should undergo treatment. The type and intensity of the treatment are usually tailored to the potential risk of the disease. Single-modal therapy means one form of treatment is recommended. The most common forms of treatment include surgical removal of the prostate, radiation therapy and hormonal therapy.
Two or more forms of treatment
Men with very aggressive cancer may be offered multi-modal therapy, which employs two or more therapies planned at the onset of treatment. National cancer guidelines offer treatment option suggestions based on the patient’s risk and potential treatment outcomes.
Better answers are here now. Schedule a no-cost and confidential appointment with a Myriad Genetics advisor to learn more about genetic testing for prostate cancer and how it could benefit you.
97% of people have coverage for genetic testing, with 93% of all patients paying $0. For those with an out-of-pocket cost, the average is < $60.
Patients and their families use test results to make life-saving medical decisions. Myriad is committed to providing patients with access to accurate and affordable genetic results.
Myriad is in-network with most major insurance plans, including Medicare. For commercial and government-funded plans, Myriad will work with your health insurance company to obtain coverage for the test ordered by your healthcare provider.
Watch how Richard and his doctor worked together to decide on the best treatment option for him based on his Prolaris results.
“Prolaris gave me the ability to maintain the lifestyle that my wife and I have lived with for many years now.”
7 million patients tested
Committed to making testing easy and affordable
Committed to keeping your genetic privacy safe
Lifetime commitment to helping you understand your results and disease
You deserve better answers about your prostate cancer. There’s no benefit in waiting for your doctor to suggest Prolaris, but there are big benefits to taking the test now. Be proactive and request our patient guide today.
Or contact a Myriad trusted advisor at